03347.HK
Hangzhou Tigermed Consulting Co., Ltd.
HKSE · Healthcare · Medical - Diagnostics & Research · CN
HKD 39.70
−0.25%Margins
Gross margin
25.8%
EBITDA margin
25.1%
EBIT margin
16.4%
Net margin
1.3%
FCF margin
16.5%
0.5%
Return on equity
0.3%
Return on assets
5.5%
Return on invested capital
0.26x
Asset turnover
HKD 1.7B
Cash from operations
HKD 3.07
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026